Dose Conversion Between Losartan and Valsartan
For adults with uncomplicated hypertension, 50 mg losartan is approximately equivalent to 80 mg valsartan, and 100 mg losartan is approximately equivalent to 160 mg valsartan 1, 2, 3, 4.
Standard Dosing Equivalence
The FDA-approved starting doses establish the conversion framework:
- Losartan 50 mg once daily ≈ Valsartan 80 mg once daily 1, 2
- Losartan 100 mg once daily ≈ Valsartan 160 mg once daily 1, 2
This 1:1.6 ratio (losartan:valsartan) is supported by direct comparative trials showing equivalent blood pressure reductions at these dose pairs 3, 4.
Clinical Evidence Supporting Equivalence
A multicenter randomized trial of 495 patients demonstrated that losartan 50 mg and valsartan 80 mg produced nearly identical reductions in diastolic blood pressure (-9.9 mmHg vs -10.1 mmHg, difference 0.2 mmHg) with similar response rates (57% vs 59%) 3. When titrated to maximum doses, losartan 100 mg and valsartan 160 mg maintained therapeutic equivalence 3.
Another trial comparing these same dose pairs found valsartan 160 mg produced a slightly higher responder rate (62%) than losartan 100 mg (55%, p=0.02), though both achieved significant blood pressure reductions 4. This suggests valsartan 160 mg may have marginal superiority over losartan 100 mg at peak doses, but the clinical difference is modest.
Practical Conversion Algorithm
When switching between these agents:
- From losartan 50 mg → switch to valsartan 80 mg once daily
- From losartan 100 mg → switch to valsartan 160 mg once daily
- From valsartan 80 mg → switch to losartan 50 mg once daily
- From valsartan 160 mg → switch to losartan 100 mg once daily
Monitor blood pressure 2-4 weeks after switching, as the antihypertensive effect stabilizes within 2 weeks and reaches maximum by 4 weeks 1.
Important Caveats
Do not combine valsartan tablets and oral suspension on a milligram-per-milligram basis, as the suspension has 60% higher systemic exposure than tablets 1. This conversion applies only to tablet formulations.
Both agents are first-line antihypertensive drugs per current guidelines 5, 6, and the choice between them should consider that losartan uniquely reduces serum uric acid levels (6.0 to 5.7 mg/dL), while valsartan slightly increases them (5.9 to 6.0 mg/dL, p=0.001) 3. This may favor losartan in patients with hyperuricemia or gout risk.
For patients requiring more intensive blood pressure control, both guidelines recommend adding a diuretic or calcium channel blocker rather than exceeding these maximum doses 5, 6.